Collaborate Disseminate
Type 2 diabetes can take years to develop, and if caught early it is an entirely preventable disease. A new study suggests a particular blood biomarker could be used to identify those patients on the way to a diabetes diagnosis but yet to display sympt… Continue reading Blood biomarker promises to identify diabetes before symptoms develop
A new study has found people with elevated blood levels of a protein called prostasin face a significantly higher risk of developing diabetes or dying from cancer. It’s unclear at this point whether the protein plays a causal role in either disease, ho… Continue reading Diabetes and cancer death risk predicted by blood protein biomarker
A study led by researchers from the Icahn School of Medicine at Mount Sinai has homed in on a newly discovered molecular mechanism that could prevent insulin resistance in type 2 diabetics. The research indicates disrupting the expression of a certain … Continue reading Protein discovery points to entirely new way to treat type 2 diabetes
Australian scientists have demonstrated a new way to restore insulin production in pancreatic cells, using a drug that’s already approved for use in humans. The study could mark a major breakthrough towards new treatments for diabetes.Continue ReadingC… Continue reading Diabetes breakthrough restores insulin production using existing drug
Type 1 diabetes begins when beta cells in the pancreas die off, meaning a patient can no longer produce enough insulin. Scientists have now identified a cellular pathway that can contribute to the death of these cells, and found that blocking it in mice and human cells keeps the beta cells alive for longer, delaying or preventing the onset of diabetes.
Tags: Diabetes, Diabetic, Boston Children’s Hospital, Insulin, New Atlas Audio
Continue reading Blocking cellular pathway delays or prevents onset of diabetes in mice
Type 1 diabetes begins when beta cells in the pancreas die off, meaning a patient can no longer produce enough insulin. Scientists have now identified a cellular pathway that can contribute to the death of these cells, and found that blocking it in mice and human cells keeps the beta cells alive for longer, delaying or preventing the onset of diabetes.
Tags: Diabetes, Diabetic, Boston Children’s Hospital, Insulin, New Atlas Audio
Continue reading Blocking cellular pathway delays or prevents onset of diabetes in mice
Management of type 1 diabetes is a difficult balancing act that involves finger-prick sampling and insulin injections to keep blood glucose levels in check, but the notion of an “artificial pancreas” promises to lighten the load. Scientists at the Univ… Continue reading Cambridge artificial pancreas proves “life-changing” for young diabetics
A peptide called MOTS-c has shown promise in preventing type 1 diabetes, according to new tests in human cells in culture and live mice. The peptide seems to regulate the immune system, potentially leading to treatments for type 1 diabetes and other au… Continue reading Type 1 diabetes prevented in mice by immune-cell-regulating peptide
An artificial pancreas has been trialed in patients with type 2 diabetes for the first time. The device monitors a person’s blood glucose levels and automatically administers insulin when needed – and the results so far are promising.Continue ReadingCa… Continue reading Artificial pancreas trialed in patients with type 2 diabetes
Diabetes has a long list of run-on health effects, and one of them is an increased risk of cardiovascular disease. Now, scientists at Oxford have uncovered a mechanism behind that, finding high blood sugar levels “reprogram” stem cells so the white blo… Continue reading Stem cells “reprogrammed” by diabetes could increase heart attack risk